CLX - The Clorox Company
NYSE
->
Consumer Defensive
->
Household & Personal Products
Oakland,
United States
Type: Equity
CLX price evolution
CLX
| (in millions $) | 31 Jan 2025 | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $202 | $219 | ||
| Short term investments | ||||
| Net receivables | $595 | $695 | $673 | |
| Inventory | $594 | $637 | $674 | |
| Total current assets | $1576 | $1622 | $1661 | |
| Long term investments | ||||
| Property, plant & equipment | $1583 | $1675 | $1671 | |
| Goodwill & intangible assets | $1909 | $1917 | ||
| Total noncurrent assets | $4129 | $4144 | ||
| Total investments | ||||
| Total assets | $5497 | $5751 | $5805 | |
| Current liabilities | ||||
| Accounts payable | $1472 | $1486 | $1653 | |
| Deferred revenue | ||||
| Short long term debt | $88 | $193 | ||
| Total current liabilities | $1579 | $1574 | $1846 | |
| Long term debt | $2482 | $2815 | $2480 | |
| Total noncurrent liabilities | $3685 | $3704 | ||
| Total debt | $2903 | $3020 | ||
| Total liabilities | $5437 | $5259 | $5714 | |
| Shareholders' equity | ||||
| Retained earnings | $31 | $250 | $34 | |
| Other shareholder equity | -$147 | -$155 | -$155 | |
| Total shareholder equity | $328 | $91 | ||
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $202 | $367 | $183 | $319 |
| Short term investments | ||||
| Net receivables | $695 | $688 | $681 | $604 |
| Inventory | $637 | $696 | $755 | $752 |
| Total current assets | $1622 | $1828 | $1725 | $1829 |
| Long term investments | ||||
| Property, plant & equipment | $1675 | $1691 | $1676 | $1634 |
| Goodwill & intangible assets | $1909 | $1964 | $2442 | $2493 |
| Total noncurrent assets | $4129 | $4117 | $4433 | $4505 |
| Total investments | ||||
| Total assets | $5751 | $5945 | $6158 | $6334 |
| Current liabilities | ||||
| Accounts payable | $1486 | $1659 | $1469 | $1675 |
| Deferred revenue | ||||
| Short long term debt | $88 | $137 | $315 | $381 |
| Total current liabilities | $1574 | $1917 | $1784 | $2056 |
| Long term debt | $2815 | $2787 | $2788 | $2785 |
| Total noncurrent liabilities | $3685 | $3640 | $3645 | $3686 |
| Total debt | $2903 | $2924 | $3103 | $3166 |
| Total liabilities | $5259 | $5557 | $5429 | $5742 |
| Shareholders' equity | ||||
| Retained earnings | $250 | $583 | $1048 | $1036 |
| Other shareholder equity | -$155 | -$493 | -$479 | -$546 |
| Total shareholder equity | $328 | $220 | $556 | $411 |
| (in millions $) | 31 Jan 2025 | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1762 | $1903 | $1814 | |
| Cost of revenue | $1019 | $1048 | ||
| Gross Profit | $806 | $884 | $766 | |
| Operating activities | ||||
| Research & development | $33 | $32 | ||
| Selling, general & administrative | $534 | $516 | ||
| Total operating expenses | $500 | $588 | $546 | |
| Operating income | $296 | $220 | ||
| Income from continuing operations | ||||
| EBIT | $291 | -$21 | ||
| Income tax expense | $74 | $54 | $8 | |
| Interest expense | -$21 | $21 | $22 | |
| Net income | ||||
| Net income | $99 | $216 | -$51 | |
| Income (for common shares) | $216 | -$51 | ||
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $7093 | $7389 | $7107 | $7341 |
| Cost of revenue | $4045 | $4481 | $4562 | $4142 |
| Gross Profit | $3048 | $2908 | $2545 | $3199 |
| Operating activities | ||||
| Research & development | $126 | $138 | $132 | $149 |
| Selling, general & administrative | $1999 | $1917 | $1663 | $1794 |
| Total operating expenses | $2320 | $2580 | $1832 | $2200 |
| Operating income | $728 | $328 | $713 | $999 |
| Income from continuing operations | ||||
| EBIT | $476 | $316 | $704 | $990 |
| Income tax expense | $106 | $77 | $136 | $181 |
| Interest expense | $90 | $90 | $106 | $99 |
| Net income | ||||
| Net income | $280 | $149 | $462 | $710 |
| Income (for common shares) | $280 | $149 | $462 | $710 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $216 | -$51 | $93 | |
| Operating activities | ||||
| Depreciation | $59 | $58 | $57 | |
| Business acquisitions & disposals | $17 | |||
| Stock-based compensation | $19 | $26 | $16 | |
| Total cash flows from operations | $340 | $182 | $153 | |
| Investing activities | ||||
| Capital expenditures | -$81 | -$55 | -$52 | |
| Investments | ||||
| Total cash flows from investing | $89 | -$81 | -$38 | -$33 |
| Financing activities | ||||
| Dividends paid | -$151 | -$149 | -$148 | -$149 |
| Sale and purchase of stock | -$2 | $4 | -$7 | |
| Net borrowings | -$106 | -$134 | -$103 | |
| Total cash flows from financing | -$237 | -$273 | -$278 | -$259 |
| Effect of exchange rate | $2 | -$3 | -$23 | |
| Change in cash and equivalents | $75 | -$14 | -$137 | -$162 |
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | $280 | $149 | $462 | $710 |
| Operating activities | ||||
| Depreciation | $235 | $236 | $224 | $211 |
| Business acquisitions & disposals | $17 | -$85 | ||
| Stock-based compensation | $74 | $73 | $52 | $50 |
| Total cash flows from operations | $695 | $1158 | $786 | $1276 |
| Investing activities | ||||
| Capital expenditures | -$212 | -$228 | -$251 | -$331 |
| Investments | ||||
| Total cash flows from investing | -$175 | -$223 | -$229 | -$452 |
| Financing activities | ||||
| Dividends paid | -$595 | -$583 | -$571 | -$558 |
| Sale and purchase of stock | $1 | $33 | -$20 | -$802 |
| Net borrowings | -$45 | -$188 | -$83 | |
| Total cash flows from financing | -$655 | -$753 | -$689 | -$1391 |
| Effect of exchange rate | -$26 | -$6 | $12 | |
| Change in cash and equivalents | -$161 | $182 | -$138 | -$555 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 16.03 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |